Q1 results, resolving litigation, but faces trade and NIH policy challenges. Click for my look at TXG stock prospects.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

10x Genomics, Inc. (NASDAQ: TXG) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. It has announced a ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Discover the potential of Single Cell Genomics in our latest report. As it revolutionizes healthcare, identify opportunities, growth expectations, and market potential. Stay ahead with insights ...

The "Single Cell Genomics Markets: Forecasts by Analyte, Product, Workflow, User, Application and Country with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering. The ...

SNS Insider Reveals U.S. Market Dominance with a Projected USD 1,925.10 Million by 2032, Backed by Breakthroughs in Oncology and AI-Driven Single-Cell PlatformsAustin, June 11, 2025 (GLOBE NEWSWIRE) - ...

Single-cell genomics and gene expression analysis have redefined our understanding of cellular complexity by enabling the dissection of gene activity at an individual cell level. This field ...